Clinical Trials

Cinical Trial Image of a keyboard, pen, stethoscope and heart over a pink background

Patient involvement in clinical trials is crucial to our community. The first ever clinical trial for MOG-AD was announced in October of 2021!  As research moving forward, there will be more clinical trials in the near future.

Sponsored by UCB Biopharma SRL

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) (cosMOG)

Please Keep checking the link above as this Trial has started recruiting patients but not all sites have been identified

UPDATE: 3/5/2022

They are working hard to solidify the list of sites worldwide that will be participating in the trial.  While this has not completed, the trial is open for recruiting for the sites available.  Thank you for your patience and stay tuned!